NO SET ASIDE USED.

ANEON BRILLIENT, LLC - CENTER FOR DRUG EVALUATION AND RESEARCH (CDER), OFFICE OF PHARMACEUTICAL QUALITY (OPQ), QUALITY ASSURANCE SPECIALIST III

PIID: 75F40124P00387
Signed Date: Aug 22, 2024Effective Date: Aug 22, 2024End Date: Closed on Aug 29, 2025
Award $
$171K
Vendor
ANEON BRILLIENT, LLC
NAICS
541990
Signed Date
Aug 22, 2024

Key Details

Dollars Obligated
$170,693.33
Base & All Options
$170,693.33
Awarding Sub-Agency
Food and Drug Administration
Product Service Code
R499 - SUPPORT- PROFESSIONAL: OTHER
Extent Competed
NOT COMPETED UNDER SAP
Number of Offers
1
Place of Performance
BELTSVILLE, MD

Description

CENTER FOR DRUG EVALUATION AND RESEARCH (CDER), OFFICE OF PHARMACEUTICAL QUALITY (OPQ), QUALITY ASSURANCE SPECIALIST III

Context & Analysis

On Aug 22, 2024, Department of Health and Human Services obligated $170,693.33 to ANEON BRILLIENT, LLC for center for drug evaluation and research (cder), office of pharmaceutical quality (opq), quality assurance specialist iii. The award is classified under NAICS 541990 — ALL OTHER PROFESSIONAL, SCIENTIFIC, AND TECHNICAL SERVICES. Competition extent: not competed under sap with 1 offer received. The procurement used a NO SET ASIDE USED. set-aside. Performance is located in BELTSVILLE, MD. This award is one of several similar procurements from Department of Health and Human Services under NAICS 541990 — related awards are listed below.

Contractor Information

UEI: MS8HMAY331Q5
Location: RESTON, VA

Stay Updated

Get notified about new opportunities matching your interests.

Related